• $1.9m Annual Recurring Revenue (ARR) as at 30 June 2025, up 49% on prior year
• FY25 revenue of $4.7m, down 33% due to large one-off hardware sales in prior year
• Signed contracts with leading healthcare and corporate clients

Visionflex Group Limited (ASX:VFX), a leader in virtual healthcare technology, has released its Appendix 4E and Financial Report for the 12 months ending 30 June 2025. The company reported FY25 revenue of $4.7m, down 33% on the prior comparison period (FY24: $6.9m), primarily due to the delivery of a single large hardware contract with WA Primary Health Alliance in the prior period. However, recurring subscription revenue from software licenses and support was up 101% to $1.4m. At 30 June 2025, the company's contract portfolio of Annual Recurring Revenue (ARR) was $1.9m, representing growth of 49% over FY25. The gross profit margin increased by 17% on the prior comparison period to 78% (FY24: 61%), driven by the growing contribution of recurring software revenue. Staff costs increased by 39% on the prior period, reflecting strategic investment in sales, marketing and development to support growth, while operating costs decreased 6% on the prior period. The company delivered an Underlying EBITDA loss of $2.5m (FY24: $0.7m). As at 30 June 2025, VFX had cash and equivalents of $1.9m and was able to reduce legacy debt levels from $6.8m to $2.5m.

The company's Annual Recurring Revenue (ARR) was $1.9m as at 30 June 2025, representing growth of 49% over the prior financial year.

The company's core focus in the year ahead is on building a sustainable and profitable organisation that serves the community, growing ARR, increasing market share in core sectors, and delivering customer-led innovation at the forefront of connected care.